FINWIRES · TerminalLIVE
FINWIRES

Japanese Stocks Rise on US-Iran Talks Optimism Despite Manufacturer Confidence Plunging to Three-Year Low

-- Japanese shares rose at the start of trading on Wednesday, mirroring overnight gains on Wall Street, as renewed optimism over further US-Iran dialogue helped ease crude prices and lift market mood.

The Nikkei 225 gained 387.8 points or 0.7% to open at 58,265.18.

With tensions in the Strait of Hormuz worsening the global energy crunch ahead of a ceasefire expiration next week, Washington and Tehran are preparing for another round of talks in the coming days.

On Tuesday, the IMF forecast that the Bank of Japan would raise interest rates gradually but at a somewhat steeper pace than previously anticipated six months ago.

The IMF's World Economic Outlook projects that Japan's growth will slow from 1.2% in 2025 to 0.7% in 2026 and further to 0.6% in 2027, a forecast largely unchanged from its October estimates.

The Reuters Tankan poll for April showed Japanese manufacturers' confidence plunging by 11 points to plus 7, the largest monthly drop since January 2023.

The reading also translated into the first decline in three months, driven by surging oil prices and supply chain disruptions from the Middle East conflict.

Related Articles

Research

Research Alert: CFRA Maintains Buy Rating On Shares Of Quest Diagnostics

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our 12-month price target at $235. This is based on a forward P/E of 21.9x our 2026 EPS estimate, a premium to DGX's three-year forward average of 16.8x due to our view of strengthening sales and earnings growth, backed by higher health care utilization trends and some regulatory relief due to postponement of lab reimbursement cuts until at least 2027. We think lab testing providers remain a relatively well-positioned area within health care given lower policy risks, supportive testing demand, and attractive earnings growth potential. On a compounded annual basis from 2025-2028, we expect near 8% EPS growth, raising our 2026 EPS to $10.73 from $10.60 and 2027 EPS to $11.50 from $11.42. We also anticipate additional smaller M&A opportunities, along with healthy dividend increases (recent 7.5% boost; shares yield 1.7%) as cash flow generation remains supportive over the near term.

$DGX
Research

Research Alert: Pega: Q1 Results Miss, But Strength In Pega Cloud Offsets

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:PEGA reported total revenue of $430M, missing consensus by $37.2M and declining 10% Y/Y, while non-GAAP EPS of $0.46 missed by $0.23 and fell 39% Y/Y. However, Pega Cloud revenue surged 36% Y/Y to $205M, now representing 47.7% of total revenue and validating the cloud transition thesis. Pega Cloud annual contract value (ACV) acceleration remains the standout metric, growing 29% Y/Y to $906.7M and accelerating from 23% growth in Q1, demonstrating continued strong demand for the company's AI workflow automation platform. Total ACV grew 12% Y/Y to $1.62B, with backlog increasing 16% Y/Y to $2.01B providing revenue visibility. We believe the robust cash flow generation of $206.5M in free cash flow and a solid balance sheet with $474M in cash provides financial flexibility for continued AI investment. Despite near-term profitability pressure, we expect the sustained Pega Cloud momentum and strong ACV growth to support the business transformation.

$PEGA
Asia

Air New Zealand CFO to Resign

Air New Zealand (ASX:AIZ, NZE:AIR) said that Chief Financial Officer Richard Thomson has resigned, effective Aug. 28, according to a Wednesday filing with the New Zealand bourse.The airline has started the process of searching for a new CFO, the filing added.

$ASX:AIZ$NZE:AIR